Pharmaceutical Industry Payments to Authors of Neurology Clinical Practice Guidelines in Japan: A Cross-sectional Study

Overview

Journal Health Sci Rep

Specialty General Medicine

Date 2024 Sep 26

PMID 39323464

Authors

Anju Murayama

Yuki Senoo

Affiliations

Soon will be listed here.

References

Murayama A, Shin N, Higuchi K, Kohli I, Kugo H, Senoo Y . Financial conflicts of interest between infectious diseases clinical practice guideline authors and the pharmaceutical industry in Japan. Infect Dis (Lond). 2024; 56(4):330-334. DOI: 10.1080/23744235.2024.2309351. View

Schunemann H, Al-Ansary L, Forland F, Kersten S, Komulainen J, Kopp I . Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines. Ann Intern Med. 2015; 163(7):548-53. DOI: 10.7326/M14-1885. View

Ngo-Metzger Q, Moyer V, Grossman D, Ebell M, Woo M, Miller T . Conflicts of Interest in Clinical Guidelines: Update of U.S. Preventive Services Task Force Policies and Procedures. Am J Prev Med. 2017; 54(1S1):S70-S80. DOI: 10.1016/j.amepre.2017.06.034. View

Mamada H, Murayama A, Kamamoto S, Kaneda Y, Yoshida M, Sugiura S . Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan.... Arthritis Care Res (Hoboken). 2022; 75(6):1278-1286. DOI: 10.1002/acr.25032. View

Yamamoto K, Murayama A, Ozaki A, Saito H, Sawano T, Tanimoto T . Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan. Int Urogynecol J. 2020; 32(2):443-451. DOI: 10.1007/s00192-020-04547-3. View

Lenzer J, Hoffman J, Furberg C, Ioannidis J . Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. BMJ. 2013; 347:f5535. DOI: 10.1136/bmj.f5535. View

Tabatabavakili S, Khan R, Scaffidi M, Gimpaya N, Lightfoot D, Grover S . Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review. Mayo Clin Proc Innov Qual Outcomes. 2021; 5(2):466-475. PMC: 8105509. DOI: 10.1016/j.mayocpiqo.2020.09.016. View

Murayama A, Hoshi M, Saito H, Kamamoto S, Tanaka M, Kawashima M . Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019. Respiration. 2022; 101(12):1088-1098. PMC: 9811425. DOI: 10.1159/000526576. View

Murayama A, Kamamoto S, Shigeta H, Saito H, Yamashita E, Tanimoto T . Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society. Dis Esophagus. 2022; 35(10). DOI: 10.1093/dote/doac056. View

10.

Murayama A, Ozaki A, Saito H, Sawano T, Shimada Y, Yamamoto K . Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan. PLoS One. 2020; 15(10):e0239610. PMC: 7553305. DOI: 10.1371/journal.pone.0239610. View

11.

Kida F, Murayama A, Saito H, Ozaki A, Shimada Y, Tanimoto T . Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment. Liver Int. 2020; 41(3):464-469. DOI: 10.1111/liv.14761. View

12.

Murayama A, Kida F, Ozaki A, Saito H, Sawano T, Tanimoto T . Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis. Otolaryngol Head Neck Surg. 2021; 166(5):869-876. DOI: 10.1177/01945998211034724. View

13.

Murayama A, Aizawa M, Byreddy K, Higuchi K, Senoo Y . Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan. J Am Heart Assoc. 2024; 13(8):e034506. PMC: 11262514. DOI: 10.1161/JAHA.124.034506. View

14.

Murayama A, Senoo Y . Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan. BMC Med Ethics. 2024; 25(1):22. PMC: 10880373. DOI: 10.1186/s12910-024-01014-2. View

15.

Hashimoto T, Murayama A, Mamada H, Saito H, Tanimoto T, Ozaki A . Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan. Clin Microbiol Infect. 2021; 28(3):460-462. PMC: 8610564. DOI: 10.1016/j.cmi.2021.11.019. View

16.

Messe S, Smith E, Getchius T, Gronseth G . American Academy of Neurology replies to Jeanne Lenzer. BMJ. 2013; 347:f5324. DOI: 10.1136/bmj.f5324. View

17.

Saito H, Ozaki A, Sawano T, Shimada Y, Tanimoto T . Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan. JAMA Netw Open. 2019; 2(4):e192834. PMC: 6487566. DOI: 10.1001/jamanetworkopen.2019.2834. View

18.

Ahlawat A, Narayanaswami P . Financial relationships between neurologists and industry: The 2015 Open Payments database. Neurology. 2019; 92(21):1006-1013. DOI: 10.1212/WNL.0000000000007640. View

19.

Murayama A, Kugo H, Senoo Y . Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan. BMJ Open. 2024; 14(6):e086396. PMC: 11328610. DOI: 10.1136/bmjopen-2024-086396. View

20.

Steinbrook R . Guidance for guidelines. N Engl J Med. 2007; 356(4):331-3. DOI: 10.1056/NEJMp068282. View